|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 5, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00240.2002
Submitted on March 20, 2002
Accepted on August 26, 2002
1 Second Department of Surgery, Fukui Medical University, Fukui, Japan
* To whom correspondence should be addressed. E-mail: Kunitan{at}fmsrsa.fukui-med.ac.jp.
We examined the role of matrix metalloproteinase (MMP), tissue inhibitor of MMP (TIMP), and plasminogen activator in transmyocardial laser revascularization (TMLR) induced angiogenesis. TMLR was accomplished with a carbon dioxide laser in 7 dogs whose left anterior descending coronary artery (LAD) was ligated. Seven control dogs underwent only LAD ligation, and four dogs underwent a sham operation, consisting only of a left thoracotomy. Two weeks later, transmural myocardial samples were harvested from the distributions of the LAD and the left circumflex artery for substrate zymography, immunohistochemical staining, and in situ zymography. MMP-1, -2, TIMP-1, -2 and urokinase-type plasminogen activator (u-PA) levels in the distribution of the LAD were higher in the laser group than in the control or sham group. Counts of von Willebrand factor-positive microvessels and
smooth muscle actin-positive arteriolae demonstrated that the angiogenesis and ateriogenesis was promoted in the laser group and correlated directly with the number of MMP stained microvessels. We conclude that TMLR induces the expression of MMPs, TIMPs, and uPA, and that these proteinases play an important role in angiogenesis after TMLR.
This article has been cited by other articles:
![]() |
D. Spiegelstein, C. Kim, Y. Zhang, G. Li, R. D. Weisel, R.-K. Li, and T. M. Yau Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3311 - H3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, K. Tanaka, A. Ihaya, Y. Fujibayashi, S. Takamatsu, K. Morioka, M. Sasaki, T. Uesaka, T. Kimura, N. Yamada, et al. Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H408 - H415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Christman, A. J. Vardanian, Q. Fang, R. E. Sievers, H. H. Fok, and R. J. Lee Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium J. Am. Coll. Cardiol., August 4, 2004; 44(3): 654 - 660. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |